Please assess the completion status of the following clinical trial:

Trial Title: Phase 3 /Seroquel SR Acute Mania Monotherapy - US

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Provision of written informed consent~* Documented diagnosis of Bipolar Disorder, with most recent episode being manic or mixed~* Inpatient hospital admission for the first 4 days of study treatment~Exclusion Criteria:~* \>8 mood episodes within the last 12 months~* Use of prohibited medication~* Substance or alcohol abuse or dependence~* Current suicide risk or suicide attempt within last 6 months.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).